Serveur d'exploration sur le peuplier - Exploration (Accueil)

Index « Titre (en) » - entrée « cancer »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
canal < cancer < candicans  Facettes :

List of bibliographic references indexed by cancer

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]
Ident.Authors (with country if any)Title
000162 (2020) Jie Qian [République populaire de Chine] ; Wei Nie [République populaire de Chine] ; Jun Lu [République populaire de Chine] ; Lele Zhang [République populaire de Chine] ; Yanwei Zhang [République populaire de Chine] ; Bo Zhang [République populaire de Chine] ; Shuyuan Wang [République populaire de Chine] ; Minjuan Hu [République populaire de Chine] ; Jianlin Xu [République populaire de Chine] ; Yuqing Lou [République populaire de Chine] ; Yu Dong [République populaire de Chine] ; Yanjie Niu [République populaire de Chine] ; Bo Yan [République populaire de Chine] ; Runbo Zhong [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Tianqing Chu [République populaire de Chine] ; Hua Zhong [République populaire de Chine] ; Baohui Han [République populaire de Chine]Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies.
000176 (2020) Wei Nie ; Jie Qian ; Mi-Die Xu ; Kai Gu [République populaire de Chine] ; Fang-Fei Qian ; Jun Lu ; Xue-Yan Zhang ; Hui-Min Wang ; Bo Yan ; Bo Zhang ; Shu-Yuan Wang ; Fang Hu ; Chang-Hui Li ; Hua Zhong ; Bao-Hui HanPrognostic and Predictive Value of Blood Tumor Mutational Burden in Patients With Lung Cancer Treated With Docetaxel.
000224 (2020) Ashley M. Hopkins [Australie] ; Jordan Wagner [Australie] ; Ganessan Kichenadasse [Australie] ; Natansh Modi [Australie] ; Andrew Rowland [Australie] ; Michael J. Sorich [Australie]Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy.
000438 (2020) Marco Mazzotta [Italie] ; Marco Filetti [Italie] ; Mario Occhipinti [Italie] ; Daniele Marinelli [Italie] ; Stefano Scalera [Italie] ; Irene Terrenato [Italie] ; Francesca Sperati [Italie] ; Matteo Pallocca [Italie] ; Francesco Rizzo [Italie] ; Alain Gelibter [Italie] ; Andrea Botticelli [Italie] ; Giorgia Scafetta [Italie] ; Arianna Di Napoli [Italie] ; Eriseld Krasniqi [Italie] ; Laura Pizzuti [Italie] ; Maddalena Barba [Italie] ; Silvia Carpano [Italie] ; Patrizia Vici [Italie] ; Maurizio Fanciulli [Italie] ; Francesca De Nicola [Italie] ; Ludovica Ciuffreda [Italie] ; Frauke Goeman [Italie] ; Ruggero De Maria [Italie] ; Andrea Vecchione [Italie] ; Raffaele Giusti [Italie] ; Gennaro Ciliberto [Italie] ; Paolo Marchetti [Italie] ; Marcello Maugeri-Saccà [Oman]Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes.
000439 (2020) M. Chalabi [Pays-Bas] ; A. Cardona [Suisse] ; D R Nagarkar [États-Unis] ; A. Dhawahir Scala [Suisse] ; D R Gandara [États-Unis] ; A. Rittmeyer [Allemagne] ; M L Albert [États-Unis] ; T. Powles [Royaume-Uni] ; M. Kok [Pays-Bas] ; F G Herrera [Suisse]Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials.
000460 (2020) Ashley M. Hopkins [Australie] ; Ganessan Kichenadasse [Australie] ; Chris S. Karapetis [Australie] ; Andrew Rowland [Australie] ; Michael J. Sorich [Australie]Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab.
000485 (2020) Ashley M. Hopkins [Australie] ; Ganessan Kichenadasse [Australie] ; Elizabeth Garrett-Mayer [États-Unis] ; Christos S. Karapetis [Australie] ; Andrew Rowland [Australie] ; Michael J. Sorich [Australie]Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab.
000552 (2020) Julien Mazieres [France] ; Achim Rittmeyer [Allemagne] ; Shirish Gadgeel [États-Unis] ; Toyoaki Hida [Japon] ; David R. Gandara [États-Unis] ; Diego L. Cortinovis [Italie] ; Fabrice Barlesi ; Wei Yu [États-Unis] ; Christina Matheny [États-Unis] ; Marcus Ballinger [États-Unis] ; Keunchil Park [Corée du Sud]Atezolizumab vs Docetaxel in Pretreated Patients with Non-Small Cell Lung Cancer: Final Results From the Randomized Phase II POPLAR and Phase III OAK Clinical Trials.
000554 (2020) Ganessan Kichenadasse [Australie] ; John O. Miners [Australie] ; Arduino A. Mangoni [Australie] ; Andrew Rowland [Australie] ; Ashley M. Hopkins [Australie] ; Michael J. Sorich [Australie]Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.
000587 (2020) Mary C. Garvin [États-Unis] ; Johan Schijf [États-Unis] ; Sonya R. Kaufman [États-Unis] ; Courtney Konow [États-Unis] ; Dong Liang [États-Unis] ; Anne E. Nigra [États-Unis] ; Norberth H. Stracker [États-Unis] ; Rebecca J. Whelan [États-Unis] ; Gregory C. Wiles [États-Unis]A survey of trace metal burdens in increment cores from eastern cottonwood (Populus deltoides) across a childhood cancer cluster, Sandusky County, OH, USA.
000621 (2019) Ashley M. Hopkins [Australie] ; Ganessan Kichenadasse [Australie] ; Ross A. Mckinnon [Australie] ; Andrew Rowland [Australie] ; Michael J. Sorich [Australie]Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitors.
000850 (2019) Yu-Tong Chen [République populaire de Chine] ; Sharvesh Raj Seeruttun [République populaire de Chine] ; Xiang-Yuan Wu [République populaire de Chine] ; Zi-Xian Wang [République populaire de Chine]Maximum Somatic Allele Frequency in Combination With Blood-Based Tumor Mutational Burden to Predict the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer: A Pooled Analysis of the Randomized POPLAR and OAK Studies.
000B19 (2019) Yu Chen [République populaire de Chine] ; Gang Chen [République populaire de Chine] ; Jin Li [République populaire de Chine] ; Ying-Ying Huang [République populaire de Chine] ; Yi Li [République populaire de Chine] ; Jing Lin [République populaire de Chine] ; Li-Zhu Chen [République populaire de Chine] ; Jian-Ping Lu [République populaire de Chine] ; Yu-Qi Wang [République populaire de Chine] ; Chang-Xi Wang [République populaire de Chine] ; Leong Kin Pan [République populaire de Chine] ; Xue-Feng Xia [République populaire de Chine] ; Xin Yi [République populaire de Chine] ; Chuan-Ben Chen [République populaire de Chine] ; Xiong-Wei Zheng [République populaire de Chine] ; Zeng-Qing Guo [République populaire de Chine] ; Jian-Ji Pan [République populaire de Chine]Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
000B88 (2018) Sivaprasad D. Madduri [États-Unis]USPSTF Update of Guidelines on Early Detection of Prostate Cancer.
000C46 (2018) Evan Landau [États-Unis] ; Shalom Kalnicki [États-Unis]The Evolving Role of Radiation in Pancreatic Cancer.
000F54 (2018) S M L M. Looijaard [Pays-Bas] ; M S Slee-Valentijn [Pays-Bas] ; L N Groeneveldt [Pays-Bas] ; D J H. Deeg [Pays-Bas] ; M. Huisman [Pays-Bas] ; A B Maier [Pays-Bas, Australie]Do older individuals who are diagnosed with cancer have worse physical performance prior to diagnosis compared to matched controls? A longitudinal cohort study.
001041 (2018) Hannah A. Blair [Nouvelle-Zélande]Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer.
001086 (2018) Laurent Claret [France] ; Jin Y. Jin [États-Unis] ; Charles Ferté [France] ; Helen Winter [États-Unis] ; Sandhya Girish [États-Unis] ; Mark Stroh [États-Unis] ; Pei He [États-Unis] ; Marcus Ballinger [États-Unis] ; Alan Sandler [États-Unis] ; Amita Joshi [États-Unis] ; Achim Rittmeyer [Allemagne] ; David Gandara [États-Unis] ; Jean-Charles Soria [France] ; René Bruno [France]A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics.
001140 (2017) Chana Weinstock [États-Unis] ; Sean Khozin [États-Unis] ; Daniel Suzman [États-Unis] ; Lijun Zhang [États-Unis] ; Shenghui Tang [États-Unis] ; Sakar Wahby [États-Unis] ; Kirsten B. Goldberg [États-Unis] ; Geoffrey Kim [États-Unis] ; Richard Pazdur [États-Unis]U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
001240 (2017) Johan Vansteenkiste [Belgique] ; Els Wauters [Belgique] ; Keunchil Park [Corée du Sud] ; Achim Rittmeyer [Allemagne] ; Alan Sandler [États-Unis] ; Alexander Spira [États-Unis]Prospects and progress of atezolizumab in non-small cell lung cancer.
001293 (2017) Nagashree Seetharamu [États-Unis] ; Isabel R. Preeshagul [États-Unis] ; Kevin M. Sullivan [États-Unis]New PD-L1 inhibitors in non-small cell lung cancer - impact of atezolizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "cancer" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "cancer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    cancer
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020